HISI News

Current Trends in Opioid Prescriptions

Current Trends in Opioid Prescriptions President Trump in late August declared that he considered opioids to be “a national emergency,” thereby increasing the intensity of an already bright spotlight on the current state of opioid prescriptions in the United States....

CVS Health to purchase Aetna

CVS Health today agreed to acquire Aetna, one of the nation’s leading diversified health care benefits companies. The new company represents new opportunities for clients and the entire healthcare industry, and enables us to bring enhanced products and services to all...

CVS Approves Hemlibra

This Specialty TrendsRx Approval Alert focuses on Hemlibra (emicizumab-kxwh). Hemlibra [Genentech/Roche] is a subcutaneous injection approved by the U.S. Food and Drug Administration (FDA) on November 16, 2017, for routine prophylaxis to prevent or reduce the...

SilverScript 2018 Cost Reduction

SilverScript is helping to reduce costs in 2018 for members who receive treatment for diabetes.         Three long-acting injectable insulin products will be on the 2018 Choice formulary as Tier 2 drugs, representing a nearly 60% savings over 2017...

The High Cost Silver Bullet Program

Health Insurance Solutions is pleased to announce our High Cost Prescription Drug Program which is a unique solution for the rising Specialty Drug costs. These costs are expected to reach 40% of Employers overall prescription drug benefit expenditures!  There is no...

CIGNA buys Express Scripts